June 4 (NBD) - China's leading TCM producer Shandong Buchang Pharmaceuticals Co Ltd (603858.SH) said in a filing last Friday that it plans to leverage its own capital to increase its stake in Bank of Chaoyang by acquiring an additional 210 million shares for no more than 456 million yuan (71 million U.S. dollars). 

After the new deal, Buchang Pharma will hold a 8.52 percent stake in Bank of Chaoyang, which will make it the bank's largest shareholder.  

Email: lansuying@nbd.com.cn